440 results
Bioresorbable scaffolds - new evidence and clinical applications
09 May 2024
Watch this webinar with M. Haude, H. Garcia Garcia, M. Joner and B. Scheller on how to revisit the concept and new technology of BRS and much more!
Treating patients with drug-coated balloons – what is the optimal result?
12 Apr 2024
Watch this webinar with F. L. Ribichini, F. Alfonso, C. C. Frankie Tam and A. G. Zaman on how to prepare lesions for drug-coated ballons-based PCI and much more!
How did Dotter's method make its way to Europe and result in Andreas Grüntzig’s balloon catheter?
In this episode, Chiara De Biase and Jean Marco discuss how Eberhard Zeitler, inspired by Dotter's work, introduced the method in Germany. Grüntzig, known for his solid medical background and empathetic demeanor, received crucial support from colleagues. His determination, teamwork, and commitment led to the development of a flexible...
Quantitative coronary angiography vs intravascular ultrasonography to guide drug-eluting stent implantation - a randomized clinical trial
21 Mar 2024
The trial aimed to establish the non-inferiority of QCA-guided PCI compared to IVUS-guided PCI with respect to the primary endpoint of TLF at 12 months, defined as a composite of cardiac death, target vessel MI, or ischemia-driven target lesion revascularization.
Reviewer
Reviewer
Transluminal angioplasty: Why was Dotter's disruptive innovation initially rejected?
In this interview, Chiara De Biase and Jean Marco embark on a journey through the history of interventional medicine, focusing on Charles Dotter, the pioneer of transluminal angioplasty, and Andreas Grüntzig.
In this second episode, they highlight three key reasons for Charles Dotter's failure to spread his method widely in the...
Bioresorbable scaffolds - back to the future? Pros and Cons
14 Mar 2024
Watch the replay of this webinar with E. Barbato, A. Baumbach and M. Sabate. Understand the evolution process of bioresorbable scaffold technology and much more.
Minimal-metal PCI: a drug-coated balloon philosophy combined with selective lesion stenting where necessary - the hybrid approach
13 Mar 2024
Watch the replay of this webinar with P. O'Kane, D. Pan and H. Routledge to understand what factors during PCI lead to the switch from DCB to DES and much more!
A journey with Charles Dotter: his contribution to transluminal angioplasty
In this interview, Chiara De Biase and Jean Marco embark on a journey through the history of interventional medicine, focusing on Charles Dotter, the pioneer of transluminal angioplasty, and Andreas Grüntzig.
In this first episode, they discuss Dotter's groundbreaking contributions, including the first interventional transluminal angioplasty in 1964, which revolutionized...
Why and when to use DCB?
06 Mar 2024
Watch the replay of this webinar to discuss why a PCI strategy without implantation of metallic stents may be a valid alternative and wich is the supporting evidence.
60 years of transluminal angioplasty: The epic tale of two pioneers, Dotter & Grüntzig
22 Feb 2024
On 16 September 1977, Andreas Gruntzig made history and changed the face of cardiology forever. Jean Marco and Chiara De Biase embark on a journey through the history of interventional cardiology...
